Today: 27 February 2026
Subscribe
Browse Category

NYSE:UNH 29 November 2025 - 14 December 2025

UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

A federal court approved a DOJ settlement in UnitedHealth’s Amedisys merger case, requiring divestitures and a $1.1 million penalty. West Virginia filed suit against Optum over opioid sales allegations. UnitedHealth shares closed Friday at $341.84, up 1.5%. The company will report full-year 2025 earnings and 2026 guidance on Jan. 27.
14 December 2025
··
UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group shares closed Friday, Dec. 12, 2025, at $341.84, up 1.52%, capping a 5.6% weekly gain despite a broader market decline. The week included a federal court approving UnitedHealth’s $3.3 billion Amedisys acquisition with required divestitures, and a new opioid-related lawsuit filed by West Virginia against Optum.
13 December 2025
·
UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth shares closed Friday at $341.84, up 1.52%, defying a broader market decline. After-hours trading saw the stock dip to around $341.33. The company announced it will report full-year 2025 results and 2026 guidance on January 27, 2026. Managed-care stocks, including UNH, gained Friday amid renewed efforts in Congress to extend ACA subsidies.
12 December 2025
··
UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth shares closed at $336.73 on Dec. 11 and traded near $337.95 pre-market Friday, approaching a key technical level. A federal court approved the DOJ settlement for UnitedHealth’s $3.3 billion Amedisys acquisition, requiring divestiture of 164 home health and hospice sites. The stock’s 52-week range is $234.60 to $606.36. UnitedHealth and Optum also face a West Virginia lawsuit over alleged opioid oversupply.
12 December 2025
UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open

UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open

UnitedHealth Group shares closed Thursday at $336.50, up about 2.5% on volume near 7 million, as the Dow hit a record high. After-hours trading was quiet, with the stock near $336.70. UNH’s market cap stands at roughly $305 billion, still well below its 2025 peak near $600. Options activity surged, with contracts traded at about double the average share volume.
12 December 2025
··
US Stock Market Today: Dow Rockets to Record Above 48,700 as S&P 500 Hits New High, Nasdaq Slips on Oracle AI Jitters

US Stock Market Today: Dow Rockets to Record Above 48,700 as S&P 500 Hits New High, Nasdaq Slips on Oracle AI Jitters

The Dow Jones closed at a record 48,704, up 1.3%, while the S&P 500 also hit a new high at 6,900.99. The Nasdaq fell 0.25% to 23,594 as tech and AI stocks slid after Oracle shares dropped 11–13% on heavy AI spending and negative free cash flow. Three-quarters of S&P 500 stocks rose. The day followed a Fed rate cut and a spike in jobless claims.
11 December 2025
······
UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth shares climbed to $332–334 intraday on December 11, up from $319.97 on November 21, but remain down about 35% over the past year. The stock trades at a trailing P/E of 14.9×, below sector average, but a forward P/E of 19×, slightly above peers. Dividend yield stands at 2.8%, with the next payout set for December 16. DOJ probe and Medicare Advantage reset continue to weigh on outlook.
11 December 2025
·
UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

UnitedHealth Group shares closed at about $324 on December 10, 2025, down roughly 39% over the past year. The company faced a series of shocks, including the December 2024 assassination of UnitedHealthcare’s CEO and a DOJ criminal probe into Medicare Advantage billing. Revenue rose 11–12% year over year to $334.4 billion for the first nine months of 2025.
10 December 2025
··
UnitedHealth Group (UNH) Stock Today: Price, West Virginia Opioid Lawsuit, Guidance Raise and 2026 Forecasts

UnitedHealth Group (UNH) Stock Today: Price, West Virginia Opioid Lawsuit, Guidance Raise and 2026 Forecasts

UnitedHealth Group shares traded near $324 Tuesday afternoon, little changed despite a new opioid lawsuit from West Virginia and ongoing DOJ probes. The stock is up about 35% year-to-date, far outpacing the S&P 500. Management raised 2025 earnings guidance last week. Wall Street targets imply nearly 20% upside, though short-term trading models flag weakness.
9 December 2025
··
UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group shares traded near $325 on December 8, 2025, down about 34% year-to-date after surging medical costs, a major cyberattack, and DOJ investigations. The company raised 2025 EPS guidance to at least $14.90 GAAP and $16.25 adjusted. UNH went ex-dividend today for a $2.21 quarterly payout, yielding 2.7%. Analyst targets imply mid-teens upside from current levels.
8 December 2025
·
UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

UnitedHealth Group shares closed at $330.91 on December 6, down about a third in 2025 and more than 40% below their late-2024 peak. The stock swung sharply this week, driving a 400-point Dow rally on December 3 and a 150-point drop the next day. Hedge fund Epoch Investment Partners cut its stake by 82% in Q2. UnitedHealth’s medical cost ratio surged to nearly 90% in 2025, forcing a major earnings guidance cut.
6 December 2025
·
UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth shares traded at $332–$334 on December 5, 2025, rebounding from May lows in the $230s after a year marked by a DOJ probe and a major data breach. The stock remains about 45% below its December 2024 high near $610. Analysts estimate 2025 EPS at $16.29, down 41% from the prior year. Simply Wall St values UNH at $847 per share, suggesting a 60% discount to intrinsic value.
5 December 2025
··
UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group shares traded around $333–340 on December 4, 2025, down over 45% from last year’s high after a year marked by a cyberattack, DOJ investigations, and the killing of a top executive. Stephen Hemsley returned as CEO amid the turmoil. Despite the rebound from lows, the stock remains about 25–30% lower year-to-date, underperforming the S&P 500.
4 December 2025
·
UnitedHealth Group (UNH) Stock Surges as Wall Street Backs 2026 Turnaround – Price, Outlook and Key Risks

UnitedHealth Group (UNH) Stock Surges as Wall Street Backs 2026 Turnaround – Price, Outlook and Key Risks

UnitedHealth closed at $339.71 on December 3, up 4.7% after management raised guidance and analysts upgraded price targets. The stock has rebounded about 45% from its lows but remains 45% below its 52-week high. The board approved a $2.21 quarterly dividend, payable December 16. Wolfe Research lifted its price target to $375, citing margin recovery and earnings growth.
4 December 2025
·
UnitedHealth Group (UNH) Stock Today: Price, Forecast and 2026 Recovery Prospects (December 2, 2025)

UnitedHealth Group (UNH) Stock Today: Price, Forecast and 2026 Recovery Prospects (December 2, 2025)

UnitedHealth traded at $325–326 on December 2, 2025, up slightly from Monday’s close of $323.21 but down nearly 50% from late 2024 highs. The stock remains far below its 52-week peak after regulatory scrutiny, a major cyberattack, and operational missteps. Analysts maintain a “Buy” rating, with a consensus price target near $397. Recent research highlights both deep-value potential and ongoing risks.
2 December 2025
·
UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth closed Friday at $329.77, down 47% from its 52-week high and about 34–35% lower year to date. The stock remains roughly 40% above its recent low, with after-hours trading at $329.50. Regulatory probes and lawsuits continue to weigh on sentiment despite a Q3 earnings beat and a 2.7% forward dividend yield. Institutional holders control about 88% of shares, with recent filings showing mixed activity.
30 November 2025
UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth closed at $329.77 on November 28, 2025, with a market cap near $299 billion. Shares remain down 34.6% year-to-date and 44.8% over the past year, despite a 3% gain this week. The stock has underperformed the S&P 500 since Q3 earnings. Institutional buying and new analyst coverage have increased recent trading activity.
30 November 2025
·
UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group shares closed at $329.77 on Nov. 28, down about 45% over the past year amid a DOJ investigation into Medicare Advantage billing. Third-quarter revenue rose 12% to $113.2 billion, but earnings from operations fell by half. The company raised its full-year earnings outlook and added former FDA commissioner Scott Gottlieb to its board. Institutional investors hold about 88% of the float.
29 November 2025
·
1 … 5 6 7 8 9
Go toTop